Market Overview:
India digital therapeutics market size reached US$ 129.3 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 628.3 Million by 2032, exhibiting a growth rate (CAGR) of 19.00% during 2024-2032. The growing demand for high-quality software programs to deliver evidence-based therapeutic interventions, creating a significant impact on disease management and patient outcomes, is primarily driving the market growth.
Report Attribute
|
Key Statistics
|
Base Year
|
2023
|
Forecast Years
|
2024-2032
|
Historical Years
|
2018-2023
|
Market Size in 2023
|
US$ 129.3 Million |
Market Forecast in 2032
|
US$ 628.3 Million |
Market Growth Rate 2024-2032 |
19.00% |
Digital therapeutics (DTx) represents a clinically validated therapeutic approach driven by sophisticated software programs, designed to prevent, manage, or treat medical disorders or diseases. Functioning as a subset of software-as-a-medical device (SaMD), it employs software interventions to induce behavioral changes in patients, contributing to the treatment of their conditions. This rapidly evolving category of therapies relies on software applications to either independently address diseases or optimize ongoing treatments. Digital therapeutics plays a pivotal role in the prevention and management of a diverse range of conditions, including but not limited to type 2 diabetes, congestive heart failure, obesity, Alzheimer's disease, dementia, asthma, substance abuse, attention deficit hyperactivity disorder (ADHD), hypertension, anxiety, depression, among others. Beyond disease management, digital therapeutics also serves to enhance patient adherence to medications and provides valuable digital support to healthcare professionals (HCPs) in efficiently managing their patients and practices in the digital realm.Top of Form
India Digital Therapeutics Market Trends:
The digital therapeutics market in India is witnessing substantial growth, marking a paradigm shift in the healthcare landscape by integrating technology to prevent, manage, and treat a spectrum of medical disorders. Moreover, the versatility of DTx in targeting various diseases underscores its potential to revolutionize healthcare delivery and enhance accessibility to effective treatments. This innovative approach plays a pivotal role in improving patient adherence to medications, a critical factor in long-term health outcomes. Additionally, digital therapeutics facilitates healthcare professionals (HCPs) in managing their patients digitally, streamlining processes and providing valuable insights for personalized care. Besides this, the surge in smartphone adoption, increasing digital literacy, and a growing awareness of the benefits of technology-driven healthcare solutions contribute to the expanding scope of the digital therapeutics market in India. Furthermore, government initiatives and collaborations with technology companies further fuel the adoption of the approach, paving the way for a more integrated, efficient, and patient-centric healthcare ecosystem in the country. Apart from this, as the digital therapeutics landscape continues to evolve, it holds the potential to significantly impact healthcare delivery, which is expected to fuel the market growth in the coming years.
India Digital Therapeutics Market Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country level for 2024-2032. Our report has categorized the market based on application and end use.
Application Insights:
- Diabetes
- Obesity
- CVD
- CNS Disease
- Respiratory Diseases
- Smoking Cessation
- Others
The report has provided a detailed breakup and analysis of the market based on the application. This includes diabetes, obesity, CVD, CNS disease, respiratory diseases, smoking cessation, and others.
End Use Insights:
- Patients
- Providers
- Payers
- Employers
- Others
A detailed breakup and analysis of the market based on the end use have also been provided in the report. This includes patients, providers, payers, employers, and others.
Regional Insights:
- North India
- West and Central India
- South India
- East and Northeast India
The report has also provided a comprehensive analysis of all the major regional markets, which include North India, West and Central India, South India, and East and Northeast India.
Competitive Landscape:
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
India Digital Therapeutics Market Report Coverage:
Report Features |
Details |
Base Year of the Analysis |
2023 |
Historical Period |
2018-2023 |
Forecast Period |
2024-2032 |
Units |
US$ Million |
Scope of the Report |
Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Future Market Assessment:
- Application
- End Use
- Region
|
Applications Covered |
Diabetes, Obesity, CVD, CNS Disease, Respiratory Diseases, Smoking Cessation, Others |
End Uses Covered |
Patients, Providers, Payers, Employers, Others |
Regions Covered |
North India, West and Central India, South India, East and Northeast India |
Customization Scope |
10% Free Customization |
Report Price and Purchase Option |
Single User License: US$ 2699
Five User License: US$ 3699
Corporate License: US$ 4699 |
Post-Sale Analyst Support |
10-12 Weeks |
Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
- How has the India digital therapeutics market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the India digital therapeutics market?
- What is the breakup of the India digital therapeutics market on the basis of application?
- What is the breakup of the India digital therapeutics market on the basis of end use?
- What are the various stages in the value chain of the India digital therapeutics market?
- What are the key driving factors and challenges in the India digital therapeutics?
- What is the structure of the India digital therapeutics market and who are the key players?
- What is the degree of competition in the India digital therapeutics market?
Key Benefits for Stakeholders:
- IMARC’s industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the India digital therapeutics market from 2018-2032.
- The research report provides the latest information on the market drivers, challenges, and opportunities in the India digital therapeutics market.
- Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the India digital therapeutics industry and its attractiveness.
- Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.